Role of omentin in obesity paradox in lung cancer

Sheetal Parida, Sumit Siddharth, Dipali Sharma

Research output: Contribution to journalArticlepeer-review


Lung cancer remains the second-most-common cancer worldwide and is associated with the highest number of cancer-related mortality. While tobacco smoking is the most important risk factor for lung cancer, many other lifestyles and occupational factors significantly contribute. Obesity is a growing global health concern and contributes to ~30% cancer-related mortality, but unlike other lifestyle diseases, lung cancer is negatively associated with obesity. We meta-analyzed multiple case-control studies confirming increased survival and better outcomes in overweight and obese lung cancer patients. Tumor heterogeneity analysis showed significant enrichment of adipocytes and preadipocytes in normal lungs compared to lung cancers. Interestingly, one of the understudied adipokine, omentin, was significantly and consistently lower in lung neoplasms compared to normal lungs. Omentin has been examined in relation to osteoarthritis, inflammatory bowel disease, cardiovascular diseases, diabetes, chronic liver disease, psoriasis and some other cancers. Aberrant expression of omentin has been reported in solid tumors; however, little is known about its role in lung cancer. We found omentin to be consistently downregulated in lung cancers, and it exhibited a negative correlation with important transcription factors FOXA1, EN1, FOXC1 and ELK4. We, therefore, suggest that omentin may serve as a prognostic factor in lung cancer and explain the “obesity paradox” in lung cancer.

Original languageEnglish (US)
Article number275
Pages (from-to)1-17
Number of pages17
Issue number2
StatePublished - Jan 2 2021


  • Lung cancer
  • Obesity
  • Omentin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Role of omentin in obesity paradox in lung cancer'. Together they form a unique fingerprint.

Cite this